Antiulcer drugs are a specialized class of pharmaceuticals used to treat and manage peptic ulcer disease (PUD), Gastroesophageal Reflux Disease (GERD), and other acid-related disorders of the gastrointestinal tract. In 2026, the global antiulcer market is evolving toward long-acting formulations and potassium-competitive acid blockers (P-CABs), with a total gastrointestinal therapeutics market valued at approximately $43.74 Billion.
1. Major Classifications of Antiulcer Drugs
Antiulcer agents are categorized based on their mechanism of action—either by reducing the “aggressive” factors (acid/pepsin) or enhancing the “protective” factors (mucus/bicarbonate).
| Category | Mechanism of Action | Common Examples |
| Proton Pump Inhibitors (PPIs) | Irreversibly inhibits the $H^+/K^+$-ATPase pump; the most potent acid suppressors. | Omeprazole, Pantoprazole, Rabeprazole, Lansoprazole. |
| H2-Receptor Antagonists | Competitively blocks histamine at H2 receptors on parietal cells. | Famotidine, Cimetidine, Ranitidine. |
| P-CABs (2026 Trend) | Potassium-competitive acid blockers; faster onset than traditional PPIs. | Vonoprazan, Tegoprazan. |
| Mucosal Protectives | Forms a physical barrier over the ulcer or stimulates mucus production. | Sucralfate, Bismuth subsalicylate, Misoprostol. |
| Antacids | Directly neutralizes existing gastric acid to provide rapid symptom relief. | Magnesium Hydroxide, Aluminum Hydroxide. |
| Anti-H. pylori Kits | Combination of antibiotics and PPIs to eradicate bacterial infection. | Clarithromycin + Amoxicillin + Pantoprazole. |
2. Significance of Antiulcer Manufacturing in India (2026)
As of 2026, India is the leading global supplier of generic antiulcer medications, driven by high domestic demand and a massive export footprint.
Shift to Advanced Combinations: Indian manufacturers are increasingly focusing on Fixed-Dose Combinations (FDCs), such as combining a PPI with a prokinetic (e.g., Pantoprazole + Domperidone), which addresses both acid production and gastric motility in a single dose.
Bioavailability Innovations: To improve patient compliance, Indian CDMOs are producing advanced dosage forms like Orally Disintegrating Tablets (ODT) and Sustained-Release (SR) capsules that ensure a consistent 24-hour acid suppression.
Global Cost-Efficiency: Through the Production Linked Incentive (PLI) schemes of 2025-26, India has reduced its dependence on imported raw materials (APIs) for antiulcer drugs, ensuring that life-saving gastro treatments remain affordable globally.
Rise of P-CABs: In 2026, several Indian facilities have transitioned to manufacturing Vonoprazan, a next-generation acid blocker that works faster and is more stable than traditional omeprazole-based therapies.
3. Why Healthy Inc. is Your Strategic Sourcing Partner
Navigating the competitive antiulcer market requires a partner who understands the technical balance between stability and dissolution. Healthy Inc. serves as your professional gateway:
Strategic Sourcing Hub: We are associated with multiple state-of-the-art manufacturing units featuring dedicated Gastro-specialty blocks. Whether you need high-volume Enteric-Coated (EC) tablets or specialized Anti-H. pylori kits, we match you with the right facility.
Pharmacist-Led Technical Vetting: We provide “straight answers” on Stability Testing (especially for moisture-sensitive PPIs). Our team vets every batch to ensure the coating remains intact in the stomach and only releases the drug in the intestine for maximum efficacy.
Regulatory & Dossier Mastery: We simplify international trade by providing full CTD/ACTD dossiers, including long-term stability data for all climate zones, ensuring your products pass local health authority audits smoothly.
Custom Branding (OEM): Through our associated network, we offer flexible Private Labeling, allowing you to launch high-quality gastro brands with customized flavors (for syrups/antacids) and professional, export-ready packaging.
Showing all 27 results
Acyclovir Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated, Dispersible Tablets (often flavored/sweetened for palatability), packed in moisture-resistant blister strips.
Active Ingredient Strength Primary Clinical Use Acyclovir USP/BP/Ph.Eur. 200 mg HSV-1 & HSV-2 (Genital/Labial Herpes) Treatment Acyclovir USP/BP/Ph.Eur. 400 mg Recurrent HSV Suppression / Chronic Prophylaxis Acyclovir USP/BP/Ph.Eur. 800 mg Varicella (Chickenpox) & Herpes Zoster (Shingles) Excipients Crospovidone / Aspartame / Flavoring Agents Superdisintegrant / Sweetener / Taste-Masking Cimetidine Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (Green or Blue). The coating masks the characteristic bitter taste and sulfur-like odor of the drug.
Active Ingredient Strength (Standard) Primary Role Cimetidine USP/BP 200 mg Prophylaxis / Maintenance Cimetidine USP/BP 400 mg Standard Therapeutic Dose Cimetidine USP/BP 800 mg Once-Daily (Bedtime) Excipients Q.S. Povidone / Magnesium Stearate Dexrabeprazole Sodium & Cinitapride Capsules
FreeDexrabeprazole Sodium and Cinitapride capsules are a combination therapy used to treat gastrointestinal disorders such as GERD, peptic ulcers, and delayed gastric emptying. This combination addresses both acid production and gut motility issues.
Dexrabeprazole Sodium & Domperidone Capsules
FreeDexrabeprazole Sodium and Domperidone capsules are combination medications used to treat acid reflux, GERD, and peptic ulcers. They combine a potent acid reducer with a medicine that speeds up stomach emptying.
Esomeprazole & Levosulpiride Capsules
FreeEsomeprazole and Levosulpiride capsules are a combination medication primarily used for gastroesophageal reflux disease (GERD) and peptic ulcers in patients who do not respond to a proton pump inhibitor (PPI) alone.
Esomeprazole Domperidone Capsules
FreeEsomeprazole and Domperidone capsules are combination medications containing two active pharmaceutical ingredients, typically formulated as pellets within a hard gelatin capsule.
Esomeprazole Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Form Esomeprazole Sodium USP/BP Equivalent to 40 mg Esomeprazole White to Off-White Cake Excipients Disodium Edetate / Sodium Hydroxide Chelating Agent / pH Adjuster *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Esomeprazole Tablets
FreeProduct Composition & Strength
We supply this product as Gastro-Resistant (Enteric Coated) Tablets. The drug is acid-labile and must pass through the stomach intact to be absorbed in the intestine.
Active Ingredient Strength (Standard) Role Esomeprazole Magnesium Trihydrate USP/BP 20 mg Maintenance / Mild GERD Esomeprazole Magnesium Trihydrate USP/BP 40 mg Erosive Esophagitis / Zollinger-Ellison Excipients Q.S. Enteric Polymers (Methacrylic Acid) Furosemide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Amber Glass Ampoules.
Active Ingredient Strength Volume Furosemide USP/BP 20 mg 2 ml Ampoule (10 mg/ml) – Standard Furosemide USP/BP 40 mg / 4 ml 4 ml Ampoule – High Dose Furosemide USP/BP 250 mg / 25 ml 25 ml Vial – Renal Failure Excipients Sodium Hydroxide / NaCl pH Adjuster / Isotonicity *Pack Sizes: Tray of 10 Ampoules, 50 Ampoules, or 100 Ampoules.
Lansoprazole & Domperidone Capsules
FreeLansoprazole and Domperidone combination capsules contain two active medications used to treat symptoms of acid reflux and slow digestion. They are often formulated as multi-particulate systems (pellets or granules) within a single hard gelatin capsule to ensure stable delivery.
Lansoprazole Capsules
FreeLansoprazole capsules are composed of an active drug and various inactive ingredients (excipients) that ensure the medication is released properly in the body.
Lansoprazole Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Form Lansoprazole Sodium USP/BP Equivalent to 30 mg Lansoprazole White Lyophilized Cake Excipients Mannitol / Meglumine / Sodium Hydroxide Bulking Agent / pH Stabilizer *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Omeprazole & Domperidone Capsules
FreeOmeprazole and Domperidone capsules are a combination medication primarily containing two active salts to treat acid reflux and indigestion.
Omeprazole Capsules
FreeOmeprazole capsules typically contain enteric-coated pellets to prevent the stomach’s acid from breaking down the medication before it can be absorbed in the small intestine.
Omeprazole Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Off-White Cake) in clear glass vials, typically accompanied by a specialized sterile solvent.
Active Ingredient Strength Reconstitution Requirement Omeprazole Sodium USP/BP 40 mg Requires provided 10 ml solvent or specific diluent Excipients Sodium Hydroxide / Disodium Edetate Alkalizing Agent / Stabilizer *Pack Sizes: Single Vial + 10 ml Solvent Ampoule, or Tray of 10 Vials.
Pantoprazole & Domperidone Capsules
FreePantoprazole and domperidone capsules are combination medications used to treat gastrointestinal conditions involving both excess acid and motility issues, such as GERD and peptic ulcers. They are most commonly available in a fixed-dose strength of 40 mg pantoprazole and 30 mg domperidone.
Pantoprazole Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Off-White Cake) in clear glass vials.
Active Ingredient Strength Reconstitution Requirement Pantoprazole Sodium USP/BP 40 mg Requires 10 ml of 0.9% Sodium Chloride Excipients Sodium Hydroxide / Edetate Disodium Alkalizing Agent / Stabilizer *Pack Sizes: Single Vial or Tray of 10 Vials. (Often packed with a 10 ml ampoule of 0.9% NaCl diluent).
Pantoprazole Tablets
FreePantoprazole Tablets IP 40 mg
Each Enteric Coated tablet contains
Pantoprazole Sodium IP
Eq. To Pantoprazole 40 mgPenta-20
Pantoprazole Tablets 20 mg
Each Enteric Coated Tablet Contains
Pantoprazole Sodium Sesquihydrate
Eq To Pantoprazole 20 mgPenta – 40
Pantoprazole Tablets 40 mg
Each Entreric Coated tablet contains
Pantoprazole Sodium Sesquihydrate
Eq. To pantoprazole 40 mgUsage: – Heartburn, acid reflux and gastro-esophageal reflux disease
Category: – Antacid & Anti ulcer drugs
Therapeutic category: – Antiulcer, Antacid
Rabeprazole & Domperidone Capsules
FreeRabeprazole and domperidone capsules are a common combination therapy used to treat gastrointestinal disorders where acid reflux is accompanied by nausea or vomiting. They are most frequently available in a fixed-dose strength of 20 mg (enteric-coated) and 30 mg (sustained-release)
Rabeprazole & Levosulpiride Capsules
FreeRabeprazole and levosulpiride capsules are a common combination used to treat gastrointestinal disorders where acid reflux is accompanied by bloating or delayed stomach emptying. They are most frequently available in a fixed-dose strength of 20 mg (enteric-coated) and 75 mg (sustained-release).
Rabeprazole Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder (White to Pale Yellow Cake) in clear glass vials.
Active Ingredient Strength Reconstitution Requirement Rabeprazole Sodium USP/BP 20 mg Requires 5 ml of Sterile Water for Injection Excipients Mannitol / Sodium Hydroxide Bulking Agent / Alkalizing Stabilizer *Pack Sizes: Single Vial or Tray of 10 Vials. (Often packed with a 5 ml diluent ampoule).
Rabeprazole Sodium Enteric Coated & Cinitapride Sustained Release Capsules
FreeRabeprazole sodium and cinitapride capsules are a combination therapy used for gastrointestinal disorders where acid reflux co-exists with slow gut movement (dysmotility). They typically come in a fixed-dose strength of 20 mg (enteric-coated) and 3 mg (sustained/extended-release).
Rabeprazole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly acid-labile Rabeprazole sodium salt.
Active Ingredient Strength Primary Clinical Function Rabeprazole Sodium INN/Ph.Eur. 10 mg Maintenance Standard: Long-term maintenance of healed erosive esophagitis and symptomatic GERD. Rabeprazole Sodium INN/Ph.Eur. 20 mg Global Clinical Standard: Acute healing of erosive esophagitis, active duodenal ulcers, and H. Pylori eradication. Excipients Light Magnesium Oxide / Mannitol / Methacrylic Acid Copolymer / Triethyl Citrate / Titanium Dioxide Alkaline Core Stabilizer / Diluent / Enteric Coating Polymer / Plasticizer (Engineered to absolutely block stomach acid and dissolve only in the alkaline duodenum) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 14-to-28 day acute gastroenterology dispensing regimens).
Ranitidine Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Solution in glass ampoules.
Active Ingredient Concentration Total Content & Format Ranitidine Hydrochloride USP/BP 25 mg / ml 50 mg in 2 ml Glass Ampoule Excipients Phenol / Potassium Di-hydrogen Phosphate Preservative / pH Buffer System (pH 6.7 to 7.3) *Pack Sizes: Tray of 10 Ampoules, 50 Ampoules, or 100 Ampoules.
Ranitidine Tablets
FreeRanitidine Hydrochloride Tablets IP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride IP
Eq. To Ranitidine 150 mgRanitidine Hydrochloride Tablets IP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride IP
Eq. To Ranitidine 300 mgRanitidine Hydrochloride Tablets USP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride USP
Eq. To Ranitidine 300 mgUsage: – Indigestion, heartburn and acid reflux, gastro-esophageal reflux disease
Category: – Antacid & Anti ulcer drugs
Therapeutic category: – Antiulcer, Antacid
